Age
stringclasses 73
values | Date of Data Entry
stringlengths 4
19
| Gender
stringclasses 3
values | Diagnosis
stringlengths 3
81
| Name of Drug
stringclasses 57
values | Dosage (gram)
stringclasses 28
values | Route
stringclasses 4
values | Frequency
stringclasses 6
values | Duration (days)
stringclasses 15
values | Indication
stringlengths 1
53
⌀ |
---|---|---|---|---|---|---|---|---|---|
40
|
19/12/2019 15:12:38
|
Male
|
hyponetrimia, hcv(+), hepatic encephalopathy, aspiration pneumonia
|
rifaximin
|
0.55
|
Oral
|
BD
|
7
|
aspiration pneumonia
|
40
|
19/12/2019 15:13:54
|
Male
|
hyponetrimia, hcv(+), hepatic encephalopathy, aspiration pneumonia
|
cefixime
|
0.2
|
Oral
|
BD
|
7
|
aspiration pneumonia
|
40
|
19/12/2019 15:15:09
|
Male
|
hyponetrimia, hcv(+), hepatic encephalopathy, aspiration pneumonia
|
metronidazole
|
0.25
|
Oral
|
TDS
|
7
|
aspiration pneumonia
|
59
|
19/12/2019 16:10:39
|
Male
|
right sided hemoporesis territory cerebral infarct, hcv, ospiration pneumonia
|
metronidazole
|
0.75
|
IV
|
TDS
|
7
|
aspiration pneumonia
|
42
|
19/12/2019 16:11:42
|
Male
|
left sided pulmonary tb
|
ceftriaxone
|
1
|
IV
|
BD
|
6
|
aspiration pneumonia
|
30
|
19/12/2019 16:26:46
|
Male
|
asthma
|
ceftazidine
|
1
|
IV
|
TDS
|
3
|
asthma
|
30
|
19/12/2019 15:50:30
|
Male
|
atypical pneumonia, mycoplasma?, itp, left sided pleural effusion
|
cefoperazone
|
1
|
IV
|
BD
|
10
|
atypical pneumonia
|
30
|
19/12/2019 15:52:41
|
Male
|
atypical pneumonia, mycoplasma?, itp, left sided pleural effusion
|
levofloxacin
|
0.5
|
IV
|
OD
|
10
|
atypical pneumonia
|
30
|
19/12/2019 15:55:06
|
Male
|
atypical pneumonia, mycoplasma?, itp, left sided pleural effusion
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
1
|
atypical pneumonia
|
30
|
19/12/2019 15:57:12
|
Male
|
atypical pneumonia, mycoplasma?, itp, left sided pleural effusion
|
clarithromycin
|
0.5
|
Oral
|
BD
|
8
|
atypical pneumonia
|
34
|
19/12/2019 16:13:24
|
Female
|
aud
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
aud
|
29
|
19/12/2019 16:14:25
|
Female
|
avi, sle
|
cefixime
|
0.2
|
Oral
|
BD
|
6
|
avi
|
29
|
19/12/2019 16:14:57
|
Female
|
avi, sle
|
ceftriaxone
|
1
|
IV
|
BD
|
8
|
avi
|
48
|
19/12/2019 15:42:45
|
Female
|
pancytopencia, aki, rvi, b,c coinfection
|
cefoperazone
|
1
|
IV
|
BD
|
5
|
b
|
48
|
19/12/2019 15:44:20
|
Female
|
pancytopenia, aki, rvi, b,c coinfection
|
septrin
|
0.96
|
Oral
|
OD
|
3
|
b
|
53
|
19/12/2019 14:48:01
|
Male
|
b(+), col, gastritis
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
b
|
87
|
19/12/2019 16:35:25
|
Female
|
pad(lt u.l), be amputation,/post op, akt
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
be amputation
|
31
|
19/12/2019 14:26:26
|
Female
|
rvi stage 4, art noise, hepatitis, bone marrow depression
|
septrin
|
0.96
|
Oral
|
OD
|
1
|
bone marrow depression
|
31
|
19/12/2019 14:28:37
|
Female
|
rvi stage 4, art noise, hepatitis, bone marrow depression
|
ceftriaxone
|
1
|
IV
|
BD
|
5
|
bone marrow depression
|
31
|
19/12/2019 14:30:33
|
Female
|
rvi, stage4, art noise, hepatitis, bone marrow depression
|
cefipime
|
1
|
IV
|
BD
|
4
|
bone marrow depression
|
49
|
19/12/2019 14:39:20
|
Female
|
bppv, type2 DM, postural hypertension
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
bppv
|
49
|
19/12/2019 14:40:19
|
Female
|
bppv, type2 DM, postural hypertension
|
cefixime
|
1
|
Oral
|
BD
|
5
|
bppv
|
50
|
19/12/2019 16:04:49
|
Female
|
bronchial asthma
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
7
|
asthma
|
48
|
19/12/2019 15:42:45
|
Female
|
pancytopencia, aki, rvi, b,c coinfection
|
cefoperazone
|
1
|
IV
|
BD
|
5
|
c coinfection
|
48
|
19/12/2019 15:44:20
|
Female
|
pancytopenia, aki, rvi, b,c coinfection
|
septrin
|
0.96
|
Oral
|
OD
|
3
|
c coinfection
|
70
|
19/12/2019 14:04:55
|
Female
|
neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm
|
ceftriaxone
|
1
|
IV
|
BD
|
2
|
ca buffalo mucosa
|
70
|
19/12/2019 14:05:42
|
Female
|
neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm
|
amikacin
|
0.5
|
IV
|
BD
|
8
|
ca buffalo mucosa
|
70
|
19/12/2019 14:06:17
|
Female
|
neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm
|
ceftazidime
|
2
|
IV
|
TDS
|
2
|
ca buffalo mucosa
|
61
|
19/12/2019 15:37:15
|
Male
|
ca lung, lung abscess
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
3
|
ca lung
|
61
|
19/12/2019 15:38:32
|
Male
|
ca lung, lung abscess
|
co-amoxiclav
|
0.625
|
Oral
|
TDS
|
3
|
ca lung
|
58
|
19/12/2019 15:38:41
|
Female
|
cap, type 2 dm
|
ceftriaxone
|
1
|
IV
|
BD
|
5
|
cap
|
58
|
19/12/2019 15:39:39
|
Female
|
cap, type 2 dm
|
metronidazole
|
0.75
|
IV
|
TDS
|
5
|
cap
|
58
|
19/12/2019 15:40:21
|
Female
|
cap, type 2 dm
|
cefixime
|
0.2
|
Oral
|
BD
|
5
|
cap
|
58
|
19/12/2019 15:40:30
|
Female
|
chronic cardiac failure, community aquired pneumonia, IHD
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
cap
|
58
|
19/12/2019 15:43:01
|
Female
|
chronic cardiac failure, community aquired pneumonia, IHD
|
coamoxiclav
|
1.2
|
IV
|
TDS
|
5
|
cap
|
69
|
19/12/2019 14:04:40
|
Female
|
gi bleeding, cap, right cerebral infarct, deep vein thrombosis of left leg
|
metronidazole
|
0.75
|
IV
|
TDS
|
5
|
cap
|
69
|
19/12/2019 14:08:30
|
Female
|
gi bleeding, cap, right cerebral infarct, deep vein thrombosis of left leg
|
cefipime
|
1
|
IV
|
BD
|
1
|
cap
|
71
|
19/12/2019 16:32:20
|
Female
|
cap, copd, drug inducwd cushing syndrome
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
5
|
cap
|
71
|
19/12/2019 17:26:59
|
Female
|
cap, copd, drug inducwd cushing syndrome
|
ceftriaxone
|
2
|
IV
|
BD
|
2
|
cap
|
71
|
19/12/2019 17:27:51
|
Female
|
cap, copd, drug inducwd cushing syndrome
|
clarithromycin
|
0.5
|
Oral
|
BD
|
5
|
cap
|
54
|
19/12/2019 14:54:10
|
Male
|
cap, h1n1(+)
|
cefoperazone
|
1
|
IV
|
BD
|
14
|
cap
|
54
|
19/12/2019 14:55:25
|
Male
|
cap, h1n1(+)
|
cefixime
|
0.2
|
Oral
|
BD
|
7
|
cap
|
54
|
19/12/2019 14:56:33
|
Male
|
cap, h1n1(+)
|
clarithromycin
|
0.5
|
Oral
|
BD
|
5
|
cap
|
36
|
19/12/2019 15:57:27
|
Male
|
he grade 3, cap
|
levofloxacin
|
0.5
|
IV
|
OD
|
4
|
cap
|
36
|
19/12/2019 15:59:01
|
Male
|
he grade 3, cap
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
1
|
cap
|
76
|
19/12/2019 14:22:00
|
Male
|
chest infection, cardiogenic shock
|
ceftriaxone
|
1
|
IV
|
OD
|
1
|
cardiogenic shock
|
78
|
19/12/2019 14:00:59
|
Male
|
copd, chest infection, cardiogenic shock
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
1
|
cardiogenic shock
|
85
|
19/12/2019 14:41:49
|
Female
|
ccf, hypertension, ida, ckd(stage 5), ?icm,
|
ceftriaxone
|
1
|
IV
|
BD
|
7
|
ccf
|
65
|
19/12/2019 16:22:50
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
co-amoxiclav
|
1
|
IV
|
TDS
|
1
|
ccf
|
65
|
19/12/2019 16:24:34
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
co-amoxiclav
|
0.625
|
Oral
|
TDS
|
2
|
ccf
|
65
|
19/12/2019 16:25:18
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
clarithromycin
|
0.5
|
Oral
|
BD
|
4
|
ccf
|
65
|
19/12/2019 16:25:52
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
ceftriaxone
|
1
|
IV
|
BD
|
2
|
ccf
|
60
|
19/12/2019 14:31:42
|
Female
|
heart failure, hcv, col, ihd, ccf, chest infection
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
1
|
ccf
|
60
|
19/12/2019 14:33:33
|
Female
|
heart failure, hcv, col, ihd, ccf, chest infection
|
co-amoxiclav
|
0.625
|
Oral
|
OD
|
5
|
ccf
|
52
|
19/12/2019 14:37:18
|
Female
|
rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft
|
septrin
|
0.96
|
Oral
|
OD
|
1
|
ccf
|
52
|
19/12/2019 14:38:22
|
Female
|
rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft
|
coamoxiclav
|
0.6
|
IV
|
OD
|
5
|
ccf
|
52
|
19/12/2019 14:39:09
|
Female
|
rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft
|
co-amoxiclav
|
1.2
|
IV
|
BD
|
2
|
ccf
|
85
|
19/12/2019 14:41:49
|
Female
|
ccf, hypertension, ida, ckd(stage 5), ?icm,
|
ceftriaxone
|
1
|
IV
|
BD
|
7
|
ccf
|
16
|
19/12/2019 13:58:05
|
Male
|
centepede bite
|
amoxicillin+flucloxacillin
|
0.5
|
Oral
|
TDS
|
5
|
centepede bite
|
70
|
19/12/2019 14:53:11
|
Male
|
septic shock, miliary tb, cerebral infarct, herpes encephalitis
|
meropenem
|
0.5
|
IV
|
BD
|
2
|
cerebral infarct
|
70
|
19/12/2019 14:54:47
|
Male
|
septic shock, miliary tb, cerebral infarct, herpes encephalitis
|
septrin
|
0.48
|
Oral
|
OD
|
1
|
cerebral infarct
|
37
|
19/12/2019 18:20:14
|
Male
|
col,koch's lung, chest infestion, chronic pancreatitis, lumbar spondylosis
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
6
|
cheat infection
|
36
|
19/12/2019 18:18:18
|
Male
|
col,koch's lung, chest infestion, chronic pancreatitis, lumbar spondylosis
|
amikacin
|
0.5
|
IV
|
BD
|
6
|
chest indection
|
63
|
19/12/2019 14:46:07
|
Male
|
acute copd, chest infection
|
ceftazidime
|
1
|
IV
|
TDS
|
4
|
chest infection
|
63
|
19/12/2019 14:47:41
|
Male
|
acute copd, chest infection
|
clarithromycin
|
1
|
Oral
|
BD
|
1
|
chest infection
|
63
|
19/12/2019 14:48:52
|
Male
|
acute copd, chest infection
|
cefixime
|
1
|
Oral
|
BD
|
7
|
chest infection
|
64
|
19/12/2019 14:42:05
|
Female
|
acute pulmonary edema, ihd, uti, type 2 dm, chest infection
|
gentamicin
|
0.8
|
IV
|
BD
|
6
|
chest infection
|
64
|
19/12/2019 14:42:34
|
Female
|
acute pulmonary edema, ihd, uti, type 2 dm, chest infection
|
ceftriaxone
|
1
|
IV
|
BD
|
5
|
chest infection
|
51
|
19/12/2019 14:03:01
|
Female
|
acute sever asthma, chest infection
|
co-amoxiclav
|
0.625
|
Oral
|
TDS
|
5
|
chest infection
|
53
|
19/12/2019 16:16:27
|
Female
|
copd, chest infection, ihd, hypertension, newly dx dm
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
3
|
chest infection
|
53
|
19/12/2019 16:17:09
|
Female
|
copd, chest infection, ihd, hypertension, newly dx dm
|
ceftriaxone
|
1
|
IV
|
BD
|
2
|
chest infection
|
53
|
19/12/2019 16:18:06
|
Female
|
copd, chest infection, ihd, hypertension, newly dx dm
|
levofloxacin
|
0.5
|
Oral
|
OD
|
7
|
chest infection
|
65
|
19/12/2019 16:22:50
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
co-amoxiclav
|
1
|
IV
|
TDS
|
1
|
chest infection
|
65
|
19/12/2019 16:24:34
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
co-amoxiclav
|
0.625
|
Oral
|
TDS
|
2
|
chest infection
|
65
|
19/12/2019 16:25:18
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
clarithromycin
|
0.5
|
Oral
|
BD
|
4
|
chest infection
|
65
|
19/12/2019 16:25:52
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
ceftriaxone
|
1
|
IV
|
BD
|
2
|
chest infection
|
19
|
19/12/2019 18:23:32
|
Female
|
chest infectio, pid
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
chest infection
|
52
|
19/12/2019 17:31:34
|
Male
|
chest infection, old stroke, af, ischaemic ihd, type2 dm, newly dx rvi
|
amoxicillin+flucloxacillin
|
0.5
|
IV
|
QID
|
1
|
chest infection
|
20
|
19/12/2019 15:20:29
|
Male
|
chest infection, retro (+)
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
chest infection
|
20
|
19/12/2019 15:22:05
|
Male
|
chest infection, retro(+)
|
septrin
|
0.06
|
Oral
|
OD
|
1
|
chest infection
|
76
|
19/12/2019 15:48:31
|
Female
|
ccf,chest infection, af ē rvr
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
1
|
chest infection
|
76
|
19/12/2019 15:49:42
|
Female
|
ccf,chest infection, af ē rvr
|
cefipime
|
1
|
IV
|
BD
|
1
|
chest infection
|
76
|
19/12/2019 15:50:24
|
Female
|
ccf,chest infection, af ē rvr
|
levofloxacin
|
1
|
IV
|
BD
|
1
|
chest infection
|
76
|
19/12/2019 15:52:54
|
Female
|
ccf,chest infection, af ē rvr
|
clarithromycin
|
0.5
|
Oral
|
BD
|
1
|
chest infection
|
80
|
19/12/2019 15:58:41
|
Male
|
acute exacerbation of copd
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
1
|
chest infection
|
60
|
19/12/2019 16:00:34
|
Male
|
ccf with hypertension, dm, chest infection
|
ceftriaxone
|
1
|
IV
|
BD
|
7
|
chest infection
|
71
|
19/12/2019 16:00:36
|
Female
|
copd, chest infection
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
4
|
chest infection
|
75
|
19/12/2019 16:02:46
|
Male
|
ckd, generalized edema, ihd, hypertension, chest infection (right upper zone)
|
ceftriaxone
|
1
|
IV
|
OD
|
5
|
chest infection
|
82
|
19/12/2019 16:02:51
|
Male
|
chest infection, copd, icm(ef) 29%, type 2 dm
|
ceftazidime
|
1
|
IV
|
TDS
|
1
|
chest infection
|
82
|
19/12/2019 16:04:05
|
Male
|
chest infection, copd, icm(ef) 29%, type 2 dm
|
ceftazidime
|
1
|
IV
|
BD
|
1
|
chest infection
|
82
|
19/12/2019 16:05:20
|
Male
|
chest infection, copd, icm(ef) 29%, type 2 dm
|
cefixime
|
0.2
|
Oral
|
BD
|
5
|
chest infection
|
77
|
19/12/2019 16:05:57
|
Female
|
copd, chest infection, hypertension, newly dx dm, t2 resp:failure(resolved)
|
ceftriaxone
|
1
|
IV
|
TDS
|
1
|
chest infection
|
77
|
19/12/2019 16:06:54
|
Female
|
copd, chest infection, hypertension, newly dx dm, t2 resp:failure(resolved)
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
1
|
chest infection
|
77
|
19/12/2019 16:07:36
|
Female
|
copd, chest infection, hypertension, newly dx dm, t2 resp:failure(resolved)
|
co-amoxiclav
|
0.625
|
Oral
|
TDS
|
10
|
chest infection
|
77
|
19/12/2019 16:08:19
|
Female
|
copd, chest infection, hypertension, newly dx dm, t2 resp:failure(resolved)
|
clarithromycin
|
0.5
|
Oral
|
BD
|
10
|
chest infection
|
57
|
19/12/2019 16:12:27
|
Male
|
col, massive ascities, chest infection
|
ceftriaxone
|
1
|
IV
|
BD
|
3
|
chest infection
|
51
|
19/12/2019 16:13:39
|
Male
|
copd, chest infection, ihd, koch's lung, newly dx dm
|
ceftazidine
|
1
|
IV
|
TDS
|
8
|
chest infection
|
51
|
19/12/2019 16:14:21
|
Male
|
copd, chest infection, ihd, koch's lung, newly dx dm
|
linezolid
|
0.6
|
Oral
|
BD
|
7
|
chest infection
|
20
|
19/12/2019 16:22:12
|
Male
|
chest infection, u/l inflammatory arthropathy on steroid, hepatitis
|
ceftriaxone
|
1
|
IV
|
BD
|
9
|
chest infection
|
19
|
19/12/2019 16:33:13
|
Female
|
chest infection, pid
|
metronidazole
|
0.75
|
IV
|
TDS
|
3
|
chest infection
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.